Switch to:
Abbott Laboratories (NYSE:ABT)
Accounts Payable
$5,948 Mil (As of Dec. 2013)

Abbott Laboratories's quarterly accounts payable increased from Jun. 2013 ($6,093 Mil) to Sep. 2013 ($6,123 Mil) but then declined from Sep. 2013 ($6,123 Mil) to Dec. 2013 ($5,948 Mil).

Abbott Laboratories's annual accounts payable declined from Dec. 2011 ($12,105 Mil) to Dec. 2012 ($10,889 Mil) and declined from Dec. 2012 ($10,889 Mil) to Dec. 2013 ($5,948 Mil).


Definition

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Abbott Laboratories Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Accts Payable 3,5463,7555,0264,9337,9447,82410,86812,10510,8895,948

Abbott Laboratories Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
Accts Payable 11,78912,10512,00011,03812,06110,8896,5016,0936,1235,948
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide